default author photo

Xing Zhang

Central South University - Hunan Cancer Hospital

Changsha, 410013

China

SCHOLARLY PAPERS

1

DOWNLOADS

53

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

PD-1 Blockade Plus Chemotherapy for EGFR-Mutant, EGFR Tyrosine Kinase Inhibitor-Pretreated Non-Small Cell Lung Cancer: A Multicenter Retrospective Study on Efficacy and Biomarker Exploration

Number of pages: 66 Posted: 31 May 2022
Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Qinghai Provincial People's Hospital - Department of Medical Oncology, Shanghai Jiao Tong University (SJTU) - Department of Pathology, Hunan University of Medicine - Department of Medical Oncology, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Huazhong University of Science and Technology - Cancer Center, Huazhong University of Science and Technology - Cancer Centre, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, Huazhong University of Science and Technology - Cancer Centre, Central South University - Department of Medical Oncology and Central South University - Department of Medical Oncology
Downloads 53 (1,041,696)

Abstract:

Loading...

Non-small cell lung cancer, immune checkpoint inhibitor, EGFR, tyrosine kinase inhibitors, lymphocyte subsets model